IL-6 is likely involved in synovial cell proliferation in the synovium in RA patients in cooperation with sIL-6R [24], and the intraperitoneal administration of the humanized anti-human IL-6R antibody significantly reduces the number of infiltrating inflammatory cells in the implanted synovium [25]. Here, IL6R is linked to rheumatoid arthritis.